Andrea Christoforou, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nootropic Agents | 3 | 2021 | 157 | 0.450 |
Why?
|
Postural Balance | 1 | 2017 | 623 | 0.410 |
Why?
|
Cognition | 12 | 2021 | 6988 | 0.370 |
Why?
|
Genome-Wide Association Study | 18 | 2021 | 12676 | 0.360 |
Why?
|
Exercise Therapy | 1 | 2017 | 922 | 0.350 |
Why?
|
Accidental Falls | 1 | 2017 | 1068 | 0.320 |
Why?
|
Polymorphism, Single Nucleotide | 18 | 2019 | 15920 | 0.320 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3691 | 0.310 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 1994 | 0.280 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8003 | 0.240 |
Why?
|
Schizophrenia | 9 | 2021 | 6930 | 0.220 |
Why?
|
Bipolar Disorder | 8 | 2016 | 5092 | 0.190 |
Why?
|
Recovery of Function | 2 | 2019 | 2981 | 0.160 |
Why?
|
Cognition Disorders | 3 | 2019 | 3976 | 0.140 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2014 | 951 | 0.140 |
Why?
|
Persistent Vegetative State | 1 | 2019 | 273 | 0.140 |
Why?
|
Coma | 1 | 2019 | 484 | 0.130 |
Why?
|
Intelligence | 2 | 2018 | 922 | 0.130 |
Why?
|
Quality of Life | 1 | 2017 | 13367 | 0.130 |
Why?
|
Consciousness Disorders | 1 | 2019 | 441 | 0.120 |
Why?
|
Consciousness | 1 | 2019 | 601 | 0.110 |
Why?
|
Nervous System Diseases | 1 | 2024 | 1663 | 0.110 |
Why?
|
Synaptic Transmission | 1 | 2019 | 1167 | 0.110 |
Why?
|
Software | 2 | 2020 | 4431 | 0.100 |
Why?
|
Independent Living | 1 | 2017 | 579 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 10 | 2019 | 17897 | 0.100 |
Why?
|
Evidence-Based Practice | 1 | 2017 | 493 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2244 | 0.100 |
Why?
|
Gait | 1 | 2017 | 810 | 0.100 |
Why?
|
Educational Status | 1 | 2019 | 2510 | 0.100 |
Why?
|
Genetic Association Studies | 3 | 2016 | 2731 | 0.100 |
Why?
|
Genetics, Behavioral | 1 | 2011 | 53 | 0.090 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2014 | 504 | 0.090 |
Why?
|
Psychometrics | 1 | 2020 | 3061 | 0.090 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2012 | 430 | 0.090 |
Why?
|
Multifactorial Inheritance | 1 | 2018 | 1387 | 0.080 |
Why?
|
Comorbidity | 1 | 2024 | 10516 | 0.080 |
Why?
|
Neuregulin-1 | 1 | 2010 | 135 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1085 | 0.080 |
Why?
|
Program Evaluation | 1 | 2017 | 2489 | 0.080 |
Why?
|
Haplotypes | 3 | 2016 | 2715 | 0.080 |
Why?
|
Mental Disorders | 3 | 2024 | 6823 | 0.080 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2007 | 48 | 0.070 |
Why?
|
Scotland | 3 | 2016 | 143 | 0.070 |
Why?
|
Caenorhabditis elegans Proteins | 2 | 2004 | 870 | 0.070 |
Why?
|
Norway | 3 | 2014 | 499 | 0.070 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 433 | 0.070 |
Why?
|
Genetic Loci | 4 | 2018 | 2623 | 0.070 |
Why?
|
Genes, Homeobox | 2 | 2004 | 285 | 0.070 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2006 | 375 | 0.060 |
Why?
|
Brain | 5 | 2018 | 27092 | 0.060 |
Why?
|
Anophthalmos | 1 | 2004 | 23 | 0.060 |
Why?
|
Meta-Analysis as Topic | 3 | 2015 | 1381 | 0.060 |
Why?
|
Microphthalmos | 1 | 2004 | 58 | 0.060 |
Why?
|
Humans | 31 | 2024 | 761208 | 0.060 |
Why?
|
Coloboma | 1 | 2004 | 60 | 0.060 |
Why?
|
Family Health | 1 | 2009 | 1254 | 0.060 |
Why?
|
SUMO-1 Protein | 1 | 2004 | 35 | 0.060 |
Why?
|
Genotype | 6 | 2016 | 12985 | 0.050 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2004 | 199 | 0.050 |
Why?
|
Repressor Proteins | 2 | 2004 | 2974 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29687 | 0.050 |
Why?
|
Aged | 11 | 2024 | 169288 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2691 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2871 | 0.050 |
Why?
|
Male | 18 | 2024 | 360693 | 0.050 |
Why?
|
DNA Methylation | 1 | 2016 | 4384 | 0.050 |
Why?
|
Female | 19 | 2024 | 392544 | 0.050 |
Why?
|
Eye Proteins | 1 | 2004 | 632 | 0.050 |
Why?
|
Pursuit, Smooth | 1 | 2019 | 38 | 0.040 |
Why?
|
Adult | 14 | 2024 | 221119 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2016 | 7851 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2018 | 58952 | 0.040 |
Why?
|
Hippocampus | 1 | 2012 | 3754 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4404 | 0.040 |
Why?
|
Genome, Human | 1 | 2012 | 4423 | 0.040 |
Why?
|
Brain Mapping | 1 | 2014 | 6635 | 0.040 |
Why?
|
Middle Aged | 12 | 2024 | 220853 | 0.040 |
Why?
|
Neuropsychological Tests | 3 | 2016 | 7046 | 0.040 |
Why?
|
Cefotaxime | 1 | 2017 | 35 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4767 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 2019 | 580 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 3707 | 0.030 |
Why?
|
Aging | 2 | 2012 | 8702 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2004 | 1967 | 0.030 |
Why?
|
Population Surveillance | 1 | 2006 | 2598 | 0.030 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2016 | 97 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2004 | 1855 | 0.030 |
Why?
|
Alleles | 1 | 2006 | 6857 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2004 | 2414 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2004 | 2881 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2019 | 80674 | 0.030 |
Why?
|
Trans-Activators | 1 | 2004 | 2846 | 0.030 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2016 | 418 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 2 | 2016 | 2401 | 0.030 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2016 | 263 | 0.030 |
Why?
|
Twins | 1 | 2015 | 340 | 0.030 |
Why?
|
Genetic Markers | 2 | 2012 | 2599 | 0.030 |
Why?
|
Adolescent | 6 | 2018 | 88298 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 1 | 2015 | 540 | 0.020 |
Why?
|
Reaction Time | 1 | 2018 | 2087 | 0.020 |
Why?
|
Sweden | 1 | 2014 | 1379 | 0.020 |
Why?
|
3' Flanking Region | 1 | 2010 | 14 | 0.020 |
Why?
|
Greece | 1 | 2011 | 340 | 0.020 |
Why?
|
5' Flanking Region | 1 | 2010 | 31 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10553 | 0.020 |
Why?
|
Anisotropy | 1 | 2014 | 1284 | 0.020 |
Why?
|
Occipital Lobe | 1 | 2012 | 374 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2113 | 0.020 |
Why?
|
Psychological Tests | 1 | 2012 | 639 | 0.020 |
Why?
|
Models, Genetic | 2 | 2012 | 3430 | 0.020 |
Why?
|
Introns | 1 | 2012 | 968 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2004 | 11856 | 0.020 |
Why?
|
Heterozygote | 1 | 2016 | 2778 | 0.020 |
Why?
|
Young Adult | 4 | 2018 | 59221 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2012 | 22174 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2009 | 294 | 0.020 |
Why?
|
Synapses | 1 | 2017 | 1755 | 0.020 |
Why?
|
Germany | 1 | 2010 | 872 | 0.020 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2007 | 41 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15721 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1506 | 0.020 |
Why?
|
Schizophrenic Psychology | 1 | 2013 | 1645 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2803 | 0.020 |
Why?
|
Lod Score | 1 | 2006 | 600 | 0.020 |
Why?
|
Axons | 1 | 2014 | 1671 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2012 | 1416 | 0.020 |
Why?
|
Phenotype | 2 | 2014 | 16575 | 0.020 |
Why?
|
Caenorhabditis elegans | 2 | 2004 | 1453 | 0.020 |
Why?
|
Family | 1 | 2016 | 3192 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36415 | 0.010 |
Why?
|
Temporal Lobe | 1 | 2012 | 1695 | 0.010 |
Why?
|
Memory | 1 | 2014 | 2190 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2787 | 0.010 |
Why?
|
Two-Hybrid System Techniques | 1 | 2004 | 459 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3603 | 0.010 |
Why?
|
Attention | 1 | 2012 | 2394 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2004 | 834 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2006 | 2340 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2004 | 1535 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2004 | 1162 | 0.010 |
Why?
|
Gene Amplification | 1 | 2004 | 1084 | 0.010 |
Why?
|
Mutation | 1 | 2004 | 30002 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9652 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2004 | 1558 | 0.010 |
Why?
|
Pedigree | 1 | 2006 | 4537 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9457 | 0.010 |
Why?
|
Exons | 1 | 2004 | 2380 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9566 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2004 | 2062 | 0.010 |
Why?
|
Protein Transport | 1 | 2004 | 1958 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39957 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3778 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41496 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12099 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2004 | 4107 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2012 | 5775 | 0.010 |
Why?
|
Rats | 1 | 2012 | 23704 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2004 | 1882 | 0.010 |
Why?
|
RNA Interference | 1 | 2004 | 2816 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 3726 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6067 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 4243 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4739 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2004 | 2667 | 0.010 |
Why?
|
Animals | 3 | 2012 | 168079 | 0.010 |
Why?
|
Risk Assessment | 1 | 2007 | 24021 | 0.000 |
Why?
|
Neurons | 1 | 2004 | 9428 | 0.000 |
Why?
|